About
About Getein Biotech, Inc
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection, infectious diseases, autoimmune diseases, universal blocking agents, and secondary antibodies. Getein Biotech, Inc was founded in 2002 and is headquartered in Nanjing, China.
Visit company website
5 years, 5 months ago
Getein Biotech, Inc is currently in a long term downtrend where the price is trading 33.8% below its 200 day moving average.
From a valuation standpoint, the stock is 16.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.0.
Getein Biotech, Inc's total revenue rose by 13.4% to $383M since the same quarter in the previous year.
Its net income has dropped by 28.1% to $101M since the same quarter in the previous year.
Finally, its free cash flow fell by 28.9% to $72M since the same quarter in the previous year.
Based on the above factors, Getein Biotech, Inc gets an overall score of 2/5.